Objectives Paratesticular rhabdomyosarcoma accounts for 7-10% of genitourinary
rhabdomyosarcoma tumors and is the 3rd most common after RMS of the prostate and …

Purpose The aim of this study was to evaluate outcomes based on surgical approach for
retroperitoneal lymph node dissection (RPLND) in patients with paratesticular …

Introduction Paratesticular lesions are common, and one subgroup is paratesticular
rhabdomyosarcoma. The latter is a relatively uncommon (but aggressive) tumour that affects …

PURPOSE: The study goal was to improve outcome in children with rhabdomyosarcoma by
comparing risk-based regimens of surgery, radiotherapy (RT) and chemotherapy. PATIENTS …

Background Children with paratesticular rhabdomyosarcoma (RMS) have both a good
prognosis and a high survival rate. The clinical behaviour and outcome of the disease in …

Purpose To report the results from International Society of Pediatric Oncology (SIOP)
Malignant Mesenchymal Tumors studies (MMT 89 and 95) of males with nonmetastatic …

Rhabdomyosarcoma (RMS) is the commonest variety of soft tissue sarcoma in children and
young adults. It represents 6.5% of all malignant tumours in paediatrics with an annual …

70 Cancer Research, Statistics, and Treatment/Volume 2/Issue 1/January-June 2019 tested
in multiple trials over the past few decades, no substantial improvement in survival has been …

Paratesticular rhabdomyosarcoma (RMS) accounts for only 7% of all the RMS cases. Due to
the limited available data, there is no consensus on the diagnosis and management of the …

Objectives To present long‐term oncological outcomes of patients with paratesticular
sarcoma treated by a multidisciplinary team. Patients and methods Patients managed at the …